好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Automated Analysis of Natural Speech in Amyotrophic Lateral Sclerosis
Aging, Dementia, and Behavioral Neurology
S15 - Behavioral and Cognitive Neurology (1:12 PM-1:24 PM)
002

To study acoustic speech signals in ALS and identify specific acoustic-prosodic markers of motor and cognitive impairments.

In amyotrophic lateral sclerosis (ALS), motor and cognitive deficits may disrupt speech. We implement automated speech recognition methods to characterize acoustic-prosodic properties of speech in patients with ALS spectrum disorders.

We recruited 44 patients with motor ALS, 23 with ALS-frontotemporal degeneration (ALS-FTD) as well as normal and FTD (non-ALS) controls. Speech samples of picture descriptions were automatically segmented with a speech activity detector. Continuous speech segments were pitch-tracked and duration measures for speech and silent pause segments were extracted. We calculated acoustic measures, including fundamental frequency (f0) range, mean speech and total speech durations, and pause rate. We compared groups and related performance on acoustic measures to clinical tests of cognitive and motor functions and cortical atrophy in MRI-T1 scans of ALS.

f0 range was impaired and related to bulbar disease (beta=-0.59, p=0.012) in ALS. f0 range was associated with MRI atrophy in primary motor cortex and left peri-Sylvian regions. Shortened speech segments (beta=0.01, p=0.02) and total speech duration (beta=0.38, p=0.006) were related to cognitive impairment. Total speech time was associated with atrophy in the frontal opercula and IFG bilaterally, the left anterior insula and the superior temporal gyri (STG). Only timed measures of speech, including pause rate and shortened speech segments, were related to respiratory restriction and associated with atrophy in the right frontal operculum and left STG.

Speech samples in ALS spectrum disorders can provide highly objective and reproducible markers of disease derived purely from the acoustic signal. Such acoustic markers relate to prosodic elements of natural language such as fluency and intonation and reflect specific motor and cognitive impairments in ALS.

Authors/Disclosures
Naomi Nevler, MD (Hospital of the University of Pennsylvania)
PRESENTER
No disclosure on file
Sharon Ash (University of Pennsylvania) No disclosure on file
Corey McMillan, PhD (University of Pennsylvania) Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Leo McCluskey, MD (Atrium Health Neurosciences Institute) No disclosure on file
David Irwin, MD (University of Pennsylvania) The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali.
No disclosure on file
No disclosure on file
Murray Grossman, MD, FAAN (University of Pennsylvania) Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.